{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:54:08Z","timestamp":1793436848867,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Children's Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11K7922N"],"award-info":[{"award-number":["11K7922N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222096\/Z\/20\/Z"],"award-info":[{"award-number":["222096\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017751","name":"NIHR BioResource","doi-asserted-by":"publisher","award":["NIHR301575"],"award-info":[{"award-number":["NIHR301575"]}],"id":[{"id":"10.13039\/100017751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clim.2024.109901","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T23:22:54Z","timestamp":1705015374000},"page":"109901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients"],"prefix":"10.1016","volume":"259","author":[{"given":"Alexandra Y.","family":"Kreins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iek","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunando","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossa","family":"Brugha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evey","family":"Howley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Graham","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Solas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Standing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Rocha-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.109901_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103595","article-title":"The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model","volume":"72","author":"Abdelnabi","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clim.2024.109901_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01348-19","article-title":"Small-molecule antiviral beta-d-N (4)-Hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance","volume":"93","author":"Agostini","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2024.109901_bb0015","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03679","article-title":"Favipiravir elicits antiviral mutagenesis during virus replication in vivo","volume":"3","author":"Arias","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.clim.2024.109901_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164691","article-title":"Lethal mutagenesis of hepatitis C virus induced by Favipiravir","volume":"11","author":"de Avila","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.109901_bb0025","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.clim.2024.109901_bb0030","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.109901_bb0035","doi-asserted-by":"crossref","first-page":"26955","DOI":"10.1073\/pnas.2014441117","article-title":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2- infected hamsters, whereas hydroxychloroquine lacks activity","volume":"117","author":"Kaptein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.109901_bb0040","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1128\/AAC.01156-16","article-title":"Distinct effects of T-705 (Favipiravir) and ribavirin on influenza virus replication and viral RNA synthesis","volume":"60","author":"Vanderlinden","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clim.2024.109901_bb0045","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/infdis\/jiac135","article-title":"Favipiravir treatment of uncomplicated influenza in adults: results of two phase 3, randomized, double-blind, placebo-controlled trials","volume":"226","author":"Hayden","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109901_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103125","article-title":"Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza","volume":"62","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clim.2024.109901_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.clim.2024.109901_bb0060","article-title":"Experimental treatment with Favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.clim.2024.109901_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(15)60232-X","article-title":"Favipiravir for children with Ebola","volume":"385","author":"Bouazza","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2024.109901_bb0070","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.109901_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01897-20","article-title":"A prospective, randomized, open-label trial of early versus late Favipiravir therapy in hospitalized patients with COVID-19","volume":"64","author":"Doi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clim.2024.109901_bb0080","article-title":"AVIFAVIR for treatment of patients with moderate COVID-19: interim results of a phase II\/III multicenter randomized clinical trial","author":"Ivashchenko","year":"2021","journal-title":"Clin. Infect. Dis. 73"},{"key":"10.1016\/j.clim.2024.109901_bb0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ijid.2021.01.055","article-title":"Efficacy of ribavirin and interferon-\u03b1 therapy for hospitalized patients with COVID- 19: a multicenter, retrospective cohort study","volume":"104","author":"Li","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109901_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coviro.2021.06.003","article-title":"Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19","volume":"50","author":"Painter","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.clim.2024.109901_bb0095","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of Remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2024.109901_bb0100","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1056\/NEJMc1806941","article-title":"Mutagenesis in norovirus in response to Favipiravir treatment","volume":"379","author":"Ruis","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.109901_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005389","article-title":"Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.clim.2024.109901_bb0110","series-title":"Forbes","author":"Haseltine","year":"2021"},{"key":"10.1016\/j.clim.2024.109901_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1926","article-title":"Norovirus infection in primary immune deficiency","volume":"27","author":"Brown","year":"2017","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.clim.2024.109901_bb0120","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jaci.2019.07.036","article-title":"A comprehensive characterization of chronic norovirus infection in immunodeficient hosts","volume":"144","author":"Brown","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.109901_bb0125","first-page":"6846873","article-title":"Successfully treated norovirus- and Sapovirus-associated diarrhea in three renal transplant patients","volume":"2018","author":"Ghusson","year":"2018","journal-title":"Case Report. Infect. Diseases"},{"key":"10.1016\/j.clim.2024.109901_bb0130","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/infdis\/jiac085","article-title":"Clinical and in-vitro evidence favoring immunoglobulin treatment of a chronic norovirus infection in a patient with common variable immunodeficiency","volume":"226","author":"van Kampen","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109901_bb0135","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ajg.2014.432","article-title":"The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency","volume":"110","author":"Woodward","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.clim.2024.109901_bb0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.clim.2024.109901_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008009","article-title":"A robust human norovirus replication model in zebrafish larvae","volume":"15","author":"Van Dycke","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2024.109901_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax1036","article-title":"PAX1 is essential for development and function of the human thymus","volume":"5","author":"Yamazaki","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2024.109901_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655354","article-title":"Current and future therapeutic approaches for Thymic stromal cell defects","volume":"12","author":"Kreins","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109901_bb0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40121-020-00383-6","article-title":"The future of respiratory syncytial virus disease prevention and treatment","volume":"10","author":"Domachowske","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.clim.2024.109901_bb0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/ACI.0000000000000695","article-title":"Replacing defective thymus function","volume":"20","author":"Kreins","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.109901_bb0170","article-title":"Simultaneous quantitation of favipiravir and its hydroxide metabolite in human plasma and hamster matrices using a UPLC-MS\/MS method","volume":"e5689","author":"Bekegnran","year":"2023","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.clim.2024.109901_bb0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2012.07.034","article-title":"Favipiravir (T-705) inhibits in vitro norovirus replication","volume":"424","author":"Rocha-Pereira","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2024.109901_bb0180","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1136\/archdischild-2023-ESDPPP.22","article-title":"Favipiravir pharmacokinetics in immunocompromised infants and children with chronic RNA viral infections","volume":"108","author":"Cheng","year":"2023","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.clim.2024.109901_bb0185","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10875-023-01478-8","article-title":"First use of Thymus transplantation in PAX1 deficiency","volume":"43","author":"Kreins","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.109901_bb0190","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/psp4.12510","article-title":"Modeling Favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials","volume":"9","author":"Madelain","year":"2020","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.clim.2024.109901_bb0195","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/JCM.01052-16","article-title":"Norovirus whole-genome sequencing by SureSelect target enrichment: a robust and sensitive method","volume":"54","author":"Brown","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.clim.2024.109901_bb0200","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (favipiravir) induces lethal mutagenesis in influenza a H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2024.109901_bb0205","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41596-021-00499-0","article-title":"Infection of zebrafish larvae with human norovirus and evaluation of the in vivo efficacy of small-molecule inhibitors","volume":"16","author":"Van Dycke","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.clim.2024.109901_bb0210","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1365-2036.2006.03128.x","article-title":"Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial","volume":"24","author":"Rossignol","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.clim.2024.109901_bb0215","first-page":"394","article-title":"Norovirus gastroenteritis successfully treated with nitazoxanide","volume":"63","author":"Siddiq","year":"2011","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.clim.2024.109901_bb0220","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.186.Supp.155.21","article-title":"The anti-infective Nitazoxanide shows strong immumodulating effects (155.21)","volume":"186","author":"Clerici","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.109901_bb0225","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.isci.2019.07.003","article-title":"The FDA-Approved Oral drug Nitazoxanide amplifies host antiviral responses and inhibits Ebola virus","volume":"19","author":"Jasenosky","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.clim.2024.109901_bb0230","doi-asserted-by":"crossref","first-page":"27148","DOI":"10.1038\/srep27148","article-title":"Thiazolides elicit anti-viral innate immunity and reduce HIV replication","volume":"6","author":"Trabattoni","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2024.109901_bb0235","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00707-18","article-title":"Nitazoxanide inhibits human norovirus replication and synergizes with ribavirin by activation of cellular antiviral response","volume":"62","author":"Dang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clim.2024.109901_bb0240","doi-asserted-by":"crossref","first-page":"veac093","DOI":"10.1093\/ve\/veac093","article-title":"Haplotype assignment of longitudinal viral deep-sequencing data using co- variation of variant frequencies","volume":"8","author":"Venturini","year":"2022","journal-title":"Virus. Evol."},{"key":"10.1016\/j.clim.2024.109901_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008937","article-title":"Favipiravir-resistant influenza a virus shows potential for transmission","volume":"17","author":"Goldhill","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2024.109901_bb0250","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.109901_bb0255","series-title":"An Introduction to Hydrogen Bonding By George A. Jeffrey (University of Pittsburgh)","author":"Dannenberg","year":"1997"},{"key":"10.1016\/j.clim.2024.109901_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004120","article-title":"Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): a randomised, double-blind, 2 \u00d7 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19","volume":"19","author":"Lowe","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.clim.2024.109901_bb0265","doi-asserted-by":"crossref","first-page":"e01217","DOI":"10.1128\/JVI.01217-18","article-title":"Determining the mutation Bias of Favipiravir in influenza virus using next- generation sequencing","volume":"93","author":"Goldhill","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2024.109901_bb0270","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1128\/AAC.01391-15","article-title":"Biochemical evaluation of the inhibition properties of Favipiravir and 2\u2019-C-methyl- cytidine triphosphates against human and mouse norovirus RNA polymerases","volume":"59","author":"Jin","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clim.2024.109901_bb0275","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrmicro.2016.48","article-title":"Human norovirus transmission and evolution in a changing world","volume":"14","author":"de Graaf","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.clim.2024.109901_bb0280","author":"Antimicrobial Drugs Advisory Committee"},{"key":"10.1016\/j.clim.2024.109901_bb0285","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with burrows-wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clim.2024.109901_bb0290","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.clim.2024.109901_bb0295","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.clim.2024.109901_bb0300","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.clim.2024.109901_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2021.138819","article-title":"Dynamic properties of SARS-CoV and SARS-CoV-2 RNA- dependent RNA polymerases studied by molecular dynamics simulations","volume":"778","author":"Itoh","year":"2021","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.clim.2024.109901_bb0310","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.str.2011.03.019","article-title":"A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions","volume":"19","author":"Shapovalov","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.clim.2024.109901_bb0315","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/v13091852","article-title":"A novel class of norovirus inhibitors targeting the viral protease with potent antiviral activity in vitro and in vivo","volume":"13","author":"Van Dycke","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.clim.2024.109901_bb0320","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent ENDPOINTS12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.clim.2024.109901_bb0325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.aquatox.2006.06.008","article-title":"The effects of dietary iron concentration on gastrointestinal and branchial assimilation of both iron and cadmium in zebrafish (Danio rerio)","volume":"79","author":"Cooper","year":"2006","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.clim.2024.109901_bb0330","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.4049\/jimmunol.1600159","article-title":"Zebrafish IRF1, IRF3, and IRF7 differentially regulate IFN\u03a61 and IFN\u03a63 expression through assembly of Homo- or Heteroprotein complexes","volume":"197","author":"Feng","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.109901_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001269","article-title":"Whole-body analysis of a viral infection: vascular endothelium is a primary target of infectious hematopoietic necrosis virus in zebrafish larvae","volume":"7","author":"Ludwig","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2024.109901_bb0340","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/JVI.79.3.1842-1852.2005","article-title":"Characterization of snakehead Rhabdovirus infection in zebrafish (<i>Danio rerio<\/i>)","volume":"79","author":"Phelan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2024.109901_bb0345","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:37:59Z","timestamp":1762547879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":69,"alternative-id":["S1521661624000123"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.109901","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.109901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109901"}}